clinical trial · NCT07368972
Study of DISC-0974-201 in Participants With IBD and Anemia
Inflammatory Bowel Disease (IBD)AnemiaInflammatory Bowel Disease (IBD); AnemiaDISC-0974Placebo
brief summary
This is a Phase 2, multicenter, randomized, double-blind placebo-controlled study of DISC-0974 to evaluate safety, tolerability, and efficacy in participants with IBD and anemia of inflammation.
started
Feb 20, 2026
primary completion
Oct 1, 2026
completion
Mar 1, 2027
last updated
Jun 30, 2026
official title
RALLY-IBD: A Phase 2 Randomized, Double-Blind Study to Evaluate the Safety, Tolerability, and Efficacy of DISC-0974 in Participants With Inflammatory Bowel Disease and Anemia of Inflammation
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol